I think had it not for CYDY to have been so many months into the cd-12 trial with management knowing that the odds were with them for full approval that it coulda been unblinded at 50% and EUA was there for the taking but it would have stopped the trial and EUA only. I strongly believe that CYDY wanted the path of least resistance in letting the data speak for itself vs have to get any any kind of on the fence decision on EUA. Nadar stated prob 15 times in the past year it’s a phase 3 study we hit the PE and we get approval unlike taht of cd-10 I think he used the term “exploratory trial for cd-10” I also think that there is a longer term view that full approval would give open label use to a whole array of different populations of covid and other indications. I am glad that they went beyond 50% and bypassed 75%. Were less than a couple weeks away from letting the world know CYDY is a game changer that has a covid-19 life saving drug. Many of us longs have known it for awhile, ans Nadar is Eager to make the data and reports public as soon as confidential discussions with FDA Health Canada MHRA are concluded. Going by what we have seen many therapeutics granted EUA on may be beneficial and benefits outweigh the risks this is a no brainer so the confidential discussions have to be all positive regarding EUA distribution, allotment, manufacturing ramp up, OWS, government grants from UK etc, what patients would be eligible to receive leronlimab? Same as in OLE or EIND or slightly different now that they have all cd-12 data. Will EUA be applied for or just given? Will they skip the whole EUA process and give full approval if Pvalue was met? Many positive things to think but can’t think of 1 reason why 3-4 different countries wanting to speak up CYDY if the drug was not a success. Cant wait to also here some news and media attention to long haulers which should be injecting first patients and prob majority of trail within early March than 8 weeks after results for that trail can be gathered. Exciting times, stressful but exciting 
9
